by Guest » Sat Oct 12, 2024 09:10 am
Tadalafil Femalefil, a formulation of tadalafil aimed at treating female sexual dysfunction, was withdrawn primarily due to concerns about its safety and efficacy. Clinical studies did not demonstrate sufficient evidence that Tadalafil Femalefil effectively improved sexual function in women. Regulatory agencies may have determined that the benefits did not outweigh the risks, leading to its withdrawal from the market.
Add your comment